Cargando…
Polatuzumab‐bendamustine‐rituximab as bridge to CD19‐directed CAR T cells in mantle cell lymphoma refractory to ibrutinib and venetoclax
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188502/ https://www.ncbi.nlm.nih.gov/pubmed/37206291 http://dx.doi.org/10.1002/jha2.655 |
| _version_ | 1785042927482830848 |
|---|---|
| author | Perriello, Vincenzo Maria Falini, Lorenza Ruggeri, Loredana Sorcini, Daniele Ballanti, Stelvio Flenghi, Leonardo Baffa, Nicodemo Covarelli, Piero Sportoletti, Paolo Pierini, Antonio Falini, Brunangelo |
| author_facet | Perriello, Vincenzo Maria Falini, Lorenza Ruggeri, Loredana Sorcini, Daniele Ballanti, Stelvio Flenghi, Leonardo Baffa, Nicodemo Covarelli, Piero Sportoletti, Paolo Pierini, Antonio Falini, Brunangelo |
| author_sort | Perriello, Vincenzo Maria |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10188502 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101885022023-05-18 Polatuzumab‐bendamustine‐rituximab as bridge to CD19‐directed CAR T cells in mantle cell lymphoma refractory to ibrutinib and venetoclax Perriello, Vincenzo Maria Falini, Lorenza Ruggeri, Loredana Sorcini, Daniele Ballanti, Stelvio Flenghi, Leonardo Baffa, Nicodemo Covarelli, Piero Sportoletti, Paolo Pierini, Antonio Falini, Brunangelo EJHaem Correspondence John Wiley and Sons Inc. 2023-04-10 /pmc/articles/PMC10188502/ /pubmed/37206291 http://dx.doi.org/10.1002/jha2.655 Text en © 2023 The Authors. eJHaem published by British Society for Haematology and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Correspondence Perriello, Vincenzo Maria Falini, Lorenza Ruggeri, Loredana Sorcini, Daniele Ballanti, Stelvio Flenghi, Leonardo Baffa, Nicodemo Covarelli, Piero Sportoletti, Paolo Pierini, Antonio Falini, Brunangelo Polatuzumab‐bendamustine‐rituximab as bridge to CD19‐directed CAR T cells in mantle cell lymphoma refractory to ibrutinib and venetoclax |
| title | Polatuzumab‐bendamustine‐rituximab as bridge to CD19‐directed CAR T cells in mantle cell lymphoma refractory to ibrutinib and venetoclax |
| title_full | Polatuzumab‐bendamustine‐rituximab as bridge to CD19‐directed CAR T cells in mantle cell lymphoma refractory to ibrutinib and venetoclax |
| title_fullStr | Polatuzumab‐bendamustine‐rituximab as bridge to CD19‐directed CAR T cells in mantle cell lymphoma refractory to ibrutinib and venetoclax |
| title_full_unstemmed | Polatuzumab‐bendamustine‐rituximab as bridge to CD19‐directed CAR T cells in mantle cell lymphoma refractory to ibrutinib and venetoclax |
| title_short | Polatuzumab‐bendamustine‐rituximab as bridge to CD19‐directed CAR T cells in mantle cell lymphoma refractory to ibrutinib and venetoclax |
| title_sort | polatuzumab‐bendamustine‐rituximab as bridge to cd19‐directed car t cells in mantle cell lymphoma refractory to ibrutinib and venetoclax |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188502/ https://www.ncbi.nlm.nih.gov/pubmed/37206291 http://dx.doi.org/10.1002/jha2.655 |
| work_keys_str_mv | AT perriellovincenzomaria polatuzumabbendamustinerituximabasbridgetocd19directedcartcellsinmantlecelllymphomarefractorytoibrutinibandvenetoclax AT falinilorenza polatuzumabbendamustinerituximabasbridgetocd19directedcartcellsinmantlecelllymphomarefractorytoibrutinibandvenetoclax AT ruggeriloredana polatuzumabbendamustinerituximabasbridgetocd19directedcartcellsinmantlecelllymphomarefractorytoibrutinibandvenetoclax AT sorcinidaniele polatuzumabbendamustinerituximabasbridgetocd19directedcartcellsinmantlecelllymphomarefractorytoibrutinibandvenetoclax AT ballantistelvio polatuzumabbendamustinerituximabasbridgetocd19directedcartcellsinmantlecelllymphomarefractorytoibrutinibandvenetoclax AT flenghileonardo polatuzumabbendamustinerituximabasbridgetocd19directedcartcellsinmantlecelllymphomarefractorytoibrutinibandvenetoclax AT baffanicodemo polatuzumabbendamustinerituximabasbridgetocd19directedcartcellsinmantlecelllymphomarefractorytoibrutinibandvenetoclax AT covarellipiero polatuzumabbendamustinerituximabasbridgetocd19directedcartcellsinmantlecelllymphomarefractorytoibrutinibandvenetoclax AT sportolettipaolo polatuzumabbendamustinerituximabasbridgetocd19directedcartcellsinmantlecelllymphomarefractorytoibrutinibandvenetoclax AT pieriniantonio polatuzumabbendamustinerituximabasbridgetocd19directedcartcellsinmantlecelllymphomarefractorytoibrutinibandvenetoclax AT falinibrunangelo polatuzumabbendamustinerituximabasbridgetocd19directedcartcellsinmantlecelllymphomarefractorytoibrutinibandvenetoclax |